Avid Bioservices Inc (CDMO)

[entdoc]

Fri.wrap. Welcome to all new PPHM passengers temporarily trapped aboard. Get used to it. At least the prose, fiction?, is occasionally compelling. We, the crew, continue efforts to fathom whether the severe jolt felt last Monday obliterating forward progress was slack water; dead air; or running aground while cutting too close to the rocks of certain offshore interests. Word on the street is someone missed a payoff, usually at the bottom of a bust. But no immediate news out of the FDA, and no countersuit from the "3rd paty" all augur well IMO. Compared to the stakes, collecting from the bagholder is chump change, so it looks like everyone is cooperating (except the bottom feeder attorneys clearly not trying to facilitate a cancer cure) to continue moving good ship PPHM toward a ecstatic greeting by waiting patients. It is telling that this bord has been co-opted primarily by market technicians and traders, with law suits walking on and off stage threateningly. The best part of that is that FTM and the science guys get a well-deserved literary pause. Interesting that PPHM fully owned subsidiary MAB manufacturer Avid gets no respect, and the frabjous PPHM pipeline is utterly ignored in this fixation on Bavi. My sense of it is that the FDA is not going to say no, and would love to drag its feet until a peek at Bavi/Pancreas trials can give them one more leg to stand on. More likely the announcement will be as early as next week that the decision has been made to allow Bavi to progress to PIII, thus leaving the window open, but prolonging the suspense of Bavi long-term efficacy. Personally, I am ready for a dose right now.